Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory Waldenstrom macroglobulinemia
scientific article
Author/s
author: Brianna Harris, Angela Dispenzieri, Martha Q Lacy, Kenneth C. Anderson, Paul G. Richardson, Morie A Gertz, Suzanne R Hayman, P Leif Bergsagel, Irene Ghobrial, Craig B Reeder, Thomas E. Witzig, Stacey Chuma, Steven P. Treon, Daniel J DeAngelo, Stephen M Ansell, John K Camoriano
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.